Seroprevalence of IgM and IgG antibodies to Toxoplasma infection in healthy and HIV-positive adults from Northern Nigeria

Journal of Infection in Developing Countries

Volumn 7, Issue 5, 2013, Pages 398-403

  Ogoina, Dimie ^a   Onyemelukwe, Geoffrey C ^b   Musa, Bolanle O ^b   Obiako, Reginald O ^b  

^a NIGER DELTA UNIVERSITY   (Nigeria)

^b AHMADU BELLO UNIVERSITY   (Nigeria)

Author keywords

Antibodies; HIV; Nigeria; Seroprevalence; Toxoplasmosis

Indexed keywords

EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; EMTRICITABINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; TENOFOVIR;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; NIGERIA; SEROPREVALENCE; TOXOPLASMOSIS;

EID: 84877894334     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.2797     Document Type: Article

References (30)

1. Montoya J and Liesenfeld O (2004) Toxoplasmosis. Lancet 363: 1965-1976.
2. Sukthana Y (2006) Toxoplasmosis; beyond animals to humans T. Parasitology 22: 137-142.
3. Luft BJ and Remington JS (1992) Toxoplasma encephalitis in AIDS. Clin Infect Dis 15: 211-222.
4. Antironi A, LarussaD,Cingolani A, Lorenzi P, Bossolasco S, Finazzi MG Bongiovanni M, Guaraldi G, Grisetti S, Vigo B, Gigli B, Mariano A, DalleNogare ER, De Marco M, Moretti F, Corsi P, Abrescia N, Rellecati P, Castagna A, Mussini C, Ammassari A, Cinque P, D'ArminioMonforte A; Italian Registry Investigative NeuroAIDS (2004) Prevalence associated factors and prognostic determinants of AIDS related toxoplasma encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis 39: 1681-1691.
5. Porter SB, Sande MA (1992) Toxoplasmosis of the CNS in the acquired immunodeficiency syndrome. N Engl J Med 327: 1643-1648.
6. Subauste S Carlos (2006) Toxoplasmosis and HIV. In; HIV in site knowledge base. March. Available at www.hivinsite.com. Retrieved June 2012.
7. Osiyemi TI, Synge EM, Agbonlahor DE, Agbauwe R (1985) The prevalence of Toxoplasma gondii antibodies in man in Plateau and meat animals in Nigeria. Trans R Soc Trop Med Hyg 79: 21-23.
8. Arene FO (1986) The prevalence of toxoplasmosis among inhabitants of the Niger Delta. Folia Parasitol (Pralia) 33: 311-314.
9. Kamani J, Mani AU, Egwu GO, Kumshe HA (2009) Seroprevalence of human infection with Toxoplasma gondii and the associated risk factors, in Maiduguri, Borno state, Nigeria. Ann Trop Med Parasitol103: 317-321.
10. Onadeko MO, Joynson DH, Payne RA (1992) The prevalence of toxoplasma infection among pregnant women in Ibadan, Nigeria. J Trop Med Hyg 95: 143-145.
11. Akanmu AS Osunkalu VO Ofomah JN Olowoselu FO (2010) Pattern of demographic risk factors in the seroprevalence of anti-Toxoplasma gondii antibodies in HIV infected patients at the Lagos University Teaching Hospital. Nig Q J Hosp Med 20:1-4.
12. Uneke CJ, Duhlinska DD, Njoku MO, Ngwu BA (2005) Seroprevalence of acquired toxoplasmosis in HIV infected and apparently healthy individuals in Jos, Nigeria. Parassitologia 47: 233-236.
13. World Health Organisation (2006) WHO clinical staging of HIV disease in adults and adolescent. Available at www.who.int. Retrieved December 2010
14. Jones JL, Kruszon Moran D, Meadey JB (2001) Toxoplasmosis gondii Infection in the USA; seroprevalence and risk factors. Am J Epidemiol 154: 357-65
15. Nissapatorn V, Azmi Noor MA, Cho SM, Fong MY, Init I (2003) Toxoplasmosis; Prevalence and risk factors. J Obst and Gynae 23: 618-624
16. Nissapatorn V, Kamaru I, Zaman A, Init L, Tan LH, Rohela M Norliza A, Chan LL, Latt HM, Anuar AK, Quek KF (2002) Seroepidemiology of toxoplasmosis among HIV infected patients and healthy blood donors. Med J Malaysia 57: 304-310.
17. Sukthana Y, Chintana T, Lekkla A (2000) Toxoplasma gondii antibody in HIV infected persons. J Med Assoc Thai 83: 681-684.
18. Boto de los Bueis A, Vega Aleman D, Galez Acebal J, Merino Muno ZD, CreaghCerquera R, Pujol de la Llave E (1998) Prevalence of latent toxoplasma infection in HIV patients. Ann Med Interna 15: 298-300.
19. Sýkora J, Zástěra M, Stanková M (1992) Toxoplasmic antibodies in sera of HIV-infected persons. Folia Parasitol (Praha) 39:177-180.
20. Daryani A, Sharif M, Meigouni M (2011) Seroprevalence of IgG and IgM anti-toxoplasma antibodies in HIV/AIDS patients, northern Iran. Asian Pac J Trop Med 4: 271-274.
21. Maija L, Kiemtore P, Tounkare A (2001) Prevalence of antitoxoplasma antibodies in patients with acquired immunodeficiency syndrome and blood donors in Bamako. Bull Soc Pathol Exot 94: 268-270.
22. Simpore J, Savadogo A, ILboudo D, Nadambega MC, Esposito M, Yara J, Pignatelli S, Pietra V, Musumeci S (2006) Toxoplasma gondii, Hepatitis C virus (HCV), Hepatitis B virus (HBV) seroprevalence and co-infection among HIV positive and negative pregnant women in Burkina Faso. J Med Virol 78: 730-733.
23. Zulma A, Sawa D, Wheeler RB, Hira SK, Luo NP, Kaleebu P, Sempala SK, Johnson JD, Holliman R(1991) Toxoplasma serology in Zambia and Ugandan patients infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg,85: 227-229.
24. Meisher YV, Mehta S, Petel U (1997) A prospective study of seroprevalence of toxoplasmosis in general population and in HIV/AIDS patients in Bombay India. J Postgrad Med 43: 93-97.
25. Gongora -Biach RA, Gonzalez- Martinez P, Castro-Sansones C, Alvarez- Moquel R, Pavia-Ruz N (1998) Antibodies against Toxoplasma gondii in patients with HIV in Yucatan. Rev Invest Clin 50: 419-222.
26. Hari KR, Modi MR, Ochan AH, Modi G (2007) Reduced risk of toxoplasma encephalitis in HIV Infected patients- a prospective study from Gauteng, South Africa. Int J STD AIDS 18: 555-558.
27. Brindle R, Holliman R, Gilles C, Wayaki P (1991) Toxoplasma antibodies in HIV positive patients from Nairobi. Trans R Soc Trop Med Hyg 85: 750-1.
28. Belanger F, Deroin F, Grangeot-Keros, Mayer L (1998) Incidence and risk factors of toxoplasmosis in a French cohort of HIV infected patients between 1988 and 1995. Int Conf AIDS 12: 306.
29. Emeka EU, Ogunrin AO, Olubunmi A (2010) Cerebellar Toxoplasmosis in HIV/AIDS: A Case Report. West Afr J Med 29: 123.
30. Ogun SA, Ojini F, Okubadejo N, Danesi M, Kolapo K, Osalusi B, Boyle B (2005) Pattern and outcome of neurological manifestations of HIV/AIDS; a review of 154 cases in a Nigerian university teaching hospital. A preliminary report. Afr J Neuro Sciences 24: 29-36.